OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Safety, Effectiveness, and Immunogenicity 6 Months After BNT162B2 mRNA Vaccine in Frail Nursing Home Residents
Pablo Montejano-Hervás, Javier Gómez‐Pavón, Olga Tornero-Torres, et al.
Drugs & Aging (2022) Vol. 39, Iss. 7, pp. 587-595
Open Access | Times Cited: 17
Pablo Montejano-Hervás, Javier Gómez‐Pavón, Olga Tornero-Torres, et al.
Drugs & Aging (2022) Vol. 39, Iss. 7, pp. 587-595
Open Access | Times Cited: 17
Showing 17 citing articles:
The EURO-FORTA (Fit fOR The Aged) List Version 2: Consensus Validation of a Clinical Tool for Improved Pharmacotherapy in Older Adults
Farhad Pazan, Christel Weiß, Martin Wehling, et al.
Drugs & Aging (2023) Vol. 40, Iss. 5, pp. 417-426
Open Access | Times Cited: 20
Farhad Pazan, Christel Weiß, Martin Wehling, et al.
Drugs & Aging (2023) Vol. 40, Iss. 5, pp. 417-426
Open Access | Times Cited: 20
SARS-CoV-2 seroreversion and all-cause mortality in nursing home residents and staff post-primary course vaccination in Belgium between February and December 2021
Eline Meyers, Liselore De Rop, Ellen Deschepper, et al.
Vaccine (2025) Vol. 51, pp. 126865-126865
Closed Access
Eline Meyers, Liselore De Rop, Ellen Deschepper, et al.
Vaccine (2025) Vol. 51, pp. 126865-126865
Closed Access
Frequently Asked Questions on Coronavirus Disease 2019 Vaccination for Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T-Cell Recipients From the American Society for Transplantation and Cellular Therapy and the American Society of Hematology
Fareed Khawaja, Genovefa A. Papanicolaou, Sanjeet Dadwal, et al.
Transplantation and Cellular Therapy (2022) Vol. 29, Iss. 1, pp. 10-18
Open Access | Times Cited: 14
Fareed Khawaja, Genovefa A. Papanicolaou, Sanjeet Dadwal, et al.
Transplantation and Cellular Therapy (2022) Vol. 29, Iss. 1, pp. 10-18
Open Access | Times Cited: 14
The COVID-19 Vaccine Gamble—By luck they worked in the oldest, frailest people
Roy L. Soiza, Megan Niven
Revista Española de Geriatría y Gerontología (2024) Vol. 59, Iss. 4, pp. 101427-101427
Closed Access | Times Cited: 2
Roy L. Soiza, Megan Niven
Revista Española de Geriatría y Gerontología (2024) Vol. 59, Iss. 4, pp. 101427-101427
Closed Access | Times Cited: 2
Immunogenicity, effectiveness and safety of COVID-19 vaccine in older adults living in nursing homes: A real-life study
Héctor Meijide Míguez, Iñaki Montes García, Miguel Ochando Gómez, et al.
Revista Española de Geriatría y Gerontología (2023) Vol. 58, Iss. 3, pp. 125-133
Open Access | Times Cited: 7
Héctor Meijide Míguez, Iñaki Montes García, Miguel Ochando Gómez, et al.
Revista Española de Geriatría y Gerontología (2023) Vol. 58, Iss. 3, pp. 125-133
Open Access | Times Cited: 7
Multiple sclerosis-disease modifying therapies affect humoral and T-cell response to mRNA COVID-19 vaccine
Federica Dominelli, Maria Antonella Zingaropoli, Matteo Tartaglia, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 9
Federica Dominelli, Maria Antonella Zingaropoli, Matteo Tartaglia, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 9
COVID-19 vaccination in cancer patients: Immune responses one year after the third dose
Roberta Campagna, Federica Dominelli, Maria Antonella Zingaropoli, et al.
Vaccine (2024) Vol. 42, Iss. 10, pp. 2687-2694
Open Access | Times Cited: 1
Roberta Campagna, Federica Dominelli, Maria Antonella Zingaropoli, et al.
Vaccine (2024) Vol. 42, Iss. 10, pp. 2687-2694
Open Access | Times Cited: 1
Headaches during/after SARS‐CoV ‐2 infection/vaccination can be primary and secondary as well as acute and chronic
Josef Finsterer, Sounira Mehri
European Journal of Neurology (2024) Vol. 31, Iss. 7
Open Access | Times Cited: 1
Josef Finsterer, Sounira Mehri
European Journal of Neurology (2024) Vol. 31, Iss. 7
Open Access | Times Cited: 1
mRNA COVID-19 vaccine safety among older adults from the Canadian National Vaccine Safety Network
Phyumar Soe, Hubert Wong, Monika Naus, et al.
Vaccine (2024) Vol. 42, Iss. 18, pp. 3819-3829
Open Access | Times Cited: 1
Phyumar Soe, Hubert Wong, Monika Naus, et al.
Vaccine (2024) Vol. 42, Iss. 18, pp. 3819-3829
Open Access | Times Cited: 1
Polypharmacy and Antibody Response to SARS-CoV-2 Vaccination in Residents of Long-Term Care Facilities: The GeroCovid Vax Study
Caterina Trevisan, Labjona Haxhiaj, Alba Malara, et al.
Drugs & Aging (2023) Vol. 40, Iss. 12, pp. 1133-1141
Closed Access | Times Cited: 2
Caterina Trevisan, Labjona Haxhiaj, Alba Malara, et al.
Drugs & Aging (2023) Vol. 40, Iss. 12, pp. 1133-1141
Closed Access | Times Cited: 2
An epidemiological survey of COVID-19 serology and its association with clinical infection among older adults– does antibody titer matter?
Dvorah Sara Shapiro, Refael Ellis, Jowad Zidan, et al.
BMC Geriatrics (2024) Vol. 24, Iss. 1
Open Access
Dvorah Sara Shapiro, Refael Ellis, Jowad Zidan, et al.
BMC Geriatrics (2024) Vol. 24, Iss. 1
Open Access
A Rapid Review of the Effects of the COVID-19 Vaccine Among Individuals Taking Clozapine
Aparna Das, Amanda T. Sawyer, Prabhava Bagla
Journal of Clinical Psychopharmacology (2024)
Closed Access
Aparna Das, Amanda T. Sawyer, Prabhava Bagla
Journal of Clinical Psychopharmacology (2024)
Closed Access
Older subjects and immunogenicity of mRNA COVID-19 vaccines
Piotr Seiffert, Dorota Religa
Elsevier eBooks (2024), pp. 649-656
Closed Access
Piotr Seiffert, Dorota Religa
Elsevier eBooks (2024), pp. 649-656
Closed Access
Risk of Death in Nursing Home Residents After COVID-19 Vaccination
Fenne Wouters, Anouk M. van Loon, Jeanine J.S. Rutten, et al.
Journal of the American Medical Directors Association (2022) Vol. 23, Iss. 10, pp. 1750-1753.e2
Open Access | Times Cited: 2
Fenne Wouters, Anouk M. van Loon, Jeanine J.S. Rutten, et al.
Journal of the American Medical Directors Association (2022) Vol. 23, Iss. 10, pp. 1750-1753.e2
Open Access | Times Cited: 2
An epidemiological survey of COVID-19 serology and its association with clinical infection among older adults – Does antibody titer matter?
Dvorah Sara Shapiro, Refael Ellis, Jowad Zidan, et al.
Research Square (Research Square) (2023)
Open Access
Dvorah Sara Shapiro, Refael Ellis, Jowad Zidan, et al.
Research Square (Research Square) (2023)
Open Access
Adis Summary of Research: Safety, Effectiveness, and Immunogenicity 6 Months After BNT162B2 mRNA Vaccine in Frail Nursing Home Residents
Julia Paik, Zaina T. Al-Salama
Drugs & Therapy Perspectives (2023) Vol. 39, Iss. 9, pp. 317-318
Closed Access
Julia Paik, Zaina T. Al-Salama
Drugs & Therapy Perspectives (2023) Vol. 39, Iss. 9, pp. 317-318
Closed Access
